AACR Resources and Experts Available for June Cancer Awareness Months
PHILADELPHIA – June is National Cancer Survivor Month and Cancer Immunotherapy Month, spearheaded by the Cancer Research Institute. To support and facilitate reporting on these important topics, the American Association for Cancer Research (AACR) has compiled the following resources.
NATIONAL CANCER SURVIVOR MONTH
AACR Cancer Progress Report 2024
The AACR’s annual Cancer Progress Report has resources on survivorship, including:
- Survivor Stories
- The report features compelling personal stories from cancer survivors of various backgrounds. Read their stories and watch video interviews on the report’s website. Contact Kathleen Medora at [email protected] to schedule interviews.
- Supporting Cancer Patients and Survivors
- This section of the report outlines challenges encountered by cancer survivors and provides strategies to support and improve their quality of life.
AACR Annual Meeting 2025
The AACR Annual Meeting 2025 offered numerous sessions on survivorship. Journalists can request access to recordings of the survivorship sessions by filling out this form.
The AACR blog, Cancer Research Catalyst, covered poster presentations from the meeting related to outcomes and survivorship:
Two relevant studies were featured in the AACR’s official press program. Read the press releases below:
- Breast Cancer Mortality in Women Ages 20-49 Significantly Dropped Between 2010 and 2020
- Cancer-related Fatigue and Depression May Lead to Decrease in Recreational Physical Activities and Quality of Life in Survivors
Cancer Research Catalyst
The AACR blog also covered recent studies presented at the 17th AACR Cancer Health Disparities Conference and the 2024 San Antonio Breast Cancer Symposium on sexual health and other lifestyle considerations for breast cancer survivors in two posts:
- Sexual Symptoms and Treatment Adherence After Breast Cancer
- Sexual Health and Other Lifestyle Considerations for Breast Cancer Survivors
CANCER IMMUNOTHERAPY MONTH
AACR Cancer Progress Report 2024
The report also highlights what immunotherapy is, how it works, and the recent advances in the field:
AACR Annual Meeting 2025
The AACR Annual Meeting 2025 included sessions on immunology, and the following studies were highlighted in the AACR’s official press program:
- Adding Perioperative Pembrolizumab to Standard of Care Improves Outcomes in Patients With Newly Diagnosed Head and Neck Cancer
- The AACR’s blog covered this study in a post.
- Neoadjuvant PD-1 Blockade in Early-stage Mismatch Repair-deficient Cancers Can Eliminate the Need for Surgery Regardless of Tumor Type
- Adjuvant PD-1 Blockade for Mismatch Repair-deficient Solid Cancers Directed by ctDNA Status Delivers Clinical Benefit
- Off-the-shelf CAR Natural Killer Cell Therapy with Logic Gates Elicits Complete Remissions in Relapsed or Refractory Blood Cancers
Cancer Research Catalyst
The AACR’s blog published a series highlighting the AACR IO conference, which encompassed the very best of basic, translational, and clinical research in immunology, inflammation, and immunotherapies for cancer:
- Inaugural AACR IO Conference Kicks Off With Celebration of Immune Checkpoints
- From Cracking Codes to Creating Cures: Leveraging Libraries to Learn the Language of T Cells
- Unleashing the Power of CAR T Cells: Insights from Day 3 of AACR IO
- Immunotherapy’s ‘Sweet’ Future: Wrapping up AACR IO 2025 With Glyco-immunology
Further, another post highlights the areas of immunotherapy that are driving progress, including cancer vaccines, anti-drug conjugates, and cellular therapies:
AACR Scientific Journals
The AACR publishes 10 peer-reviewed scientific journals, including Cancer Immunology Research, featuring leading-edge research in the field. Recent articles on cancer immunotherapy include:
- Some Patients May Experience Durable Disease Control Even After Discontinuing Immune Checkpoint Inhibitors for Side Effects
- Radiation Plus Combination Immunotherapy May Help Preserve Bladder in Some Patients With Muscle-invasive Bladder Cancer
- Adding Immunotherapy to Neoadjuvant Chemoradiation May Improve Outcomes in Esophageal Cancer
- The AACR’s blog covered this study in a post.
- AACR Journal Collection: Immuno-oncology
The AACR public relations team can provide journalists with access to any articles published in AACR journals. Please contact Kathleen Medora at [email protected] with article requests.
AACR EXPERTS
The AACR has experts on survivorship and immunotherapy available for comment. Please contact Kathleen Medora at [email protected] to connect with an expert.
ADDITIONAL RESOURCES
For additional resources related to cancer survivorship, please visit the AACR’s website.